Tissue Omega-6/Omega-3 Fatty Acid Ratio and Risk for Coronary Artery Disease

      A ratio that estimates tissue proportions of omega-6 fatty acids (linoleic acid and/or arachidonic acid [AA]) and omega-3 fatty acids (eicosapentaenoic acid [EPA], docosahexaenoic acid [DHA], and/or α-linolenic acid) has been proposed as a biomarker of risk for coronary artery disease (CAD). Use of an omega-6/omega-3 fatty acid ratio instead of either fatty acid class alone is based on theoretical reasons and has not been validated. The relationship between risk for CAD events and tissue omega-3 and omega-6 fatty acid composition was evaluated by pooling data from case-control or prospective cohort studies that examined the risk for CAD end points as a function of tissue fatty acid composition. Thirteen studies were included, 11 case-control and 2 prospective cohort studies, and case-control differences in computed averages of several fatty acids and fatty acid ratios were compared. The largest and most consistent difference was for the sum of EPA + DHA (−11% in cases, p = 0.002). Proportions of EPA, DHA, and AA were about 8% lower in cases, but none of these differences was significant. Total omega-3 and omega-6 fatty acids were lower by 7% and 4%, respectively, in cases versus controls, but only the total omega-3 fatty acid difference was significant. The AA/EPA ratio was nonsignificantly lower by 10% in cases. Fatty acid ratios generally failed to distinguish cases from controls, and any discriminatory power they had derived from the omega-3 fatty acid component. Tissue EPA + DHA appears to be the best fatty acid metric for evaluating for CAD risk.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nakamura M.T.
        • Nara T.Y.
        Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases.
        Annu Rev Nutr. 2004; 24: 345-376
        • Simopoulos A.P.
        • Cleland L.G.
        Omega-6/Omega-3 Essential Fatty Acid Ratio. Vol 92. Karger, Farmington, CT2003
        • Tapiero H.
        • Ba G.N.
        • Couvreur P.
        • Tew K.D.
        Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.
        Biomed Pharmacother. 2002; 56: 215-222
        • Brown W.J.
        • Chambers K.
        • Doody A.
        Phospholipase A2 (PLA2) enzymes in membrane trafficking.
        Traffic. 2003; 4: 214-221
        • Zhou L.
        • Nilsson A.
        Sources of eicosanoid precursor fatty acid pools in tissues.
        J Lipid Res. 2001; 42: 1521-1542
        • Blok W.L.
        • Katan M.B.
        • van der Meer J.W.
        Modulation of inflammation and cytokine production by dietary (n-3) fatty acids.
        J Nutr. 1996; 126: 1515-1533
        • Lands W.E.
        Diets could prevent many diseases.
        Lipids. 2003; 38: 317-321
        • Rupp H.
        • Wagner D.
        • Rupp T.
        • Schulte L.M.
        • Maisch B.
        Risk stratification by the “EPA+DHA level” and the “EPA/AA ratio” focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
        Herz. 2004; 29: 673-685
        • Albert C.M.
        • Campos H.
        • Stampfer M.J.
        • Ridker P.M.
        • Manson J.E.
        • Willett W.C.
        • Ma J.
        Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
        N Engl J Med. 2002; 346: 1113-1118
        • Erkkila A.T.
        • Lehto S.
        • Pyorala K.
        • Uusitupa M.I.
        n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.
        Am J Clin Nutr. 2003; 78: 65-71
        • Guallar E.
        • Hennekens C.H.
        • Sacks F.M.
        • Willett W.C.
        • Stampfer M.J.
        A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians.
        J Am Coll Cardiol. 1995; 25: 387-394
        • Hallgren C.G.
        • Hallmans G.
        • Jansson J.H.
        • Marklund S.L.
        • Huhtasaari F.
        • Schutz A.
        • Stromberg U.
        • Vessby B.
        • Skerfving S.
        Markers of high fish intake are associated with decreased risk of a first myocardial infarction.
        Br J Nutr. 2001; 86: 397-404
        • Lea E.J.
        • Jones S.P.
        • Hamilton D.V.
        The fatty acids of erythrocytes of myocardial infarction patients.
        Atherosclerosis. 1982; 41: 363-369
        • Lemaitre R.N.
        • King I.B.
        • Raghunathan T.E.
        • Pearce R.M.
        • Weinmann S.
        • Knopp R.H.
        • Copass M.K.
        • Cobb L.A.
        • Siscovick D.S.
        Cell membrane trans-fatty acids and the risk of primary cardiac arrest.
        Circulation. 2002; 105: 697-701
        • Lemaitre R.N.
        • King I.B.
        • Mozaffarian D.
        • Kuller L.H.
        • Tracy R.P.
        • Siscovick D.S.
        N-3 polyunsaturated fatty acids, fatal ischemic heart disease and non-fatal myocardial infarction in older adults.
        Am J Clin Nutr. 2003; 77: 319-325
        • Luostarinen R.
        • Boberg M.
        • Saldeen T.
        Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death.
        Atherosclerosis. 1993; 99: 187-193
        • Miettinen T.A.
        • Naukkarinen V.
        • Huttunen J.K.
        • Mattila S.
        • Kumlin T.
        Fatty-acid composition of serum lipids predicts myocardial infarction.
        BMJ. 1982; 285: 993-996
        • Simon J.A.
        • Hodgkins M.L.
        • Browner W.S.
        • Neuhaus J.M.
        • Bernert Jr, J.T.
        • Hulley S.B.
        Serum fatty acids and the risk of coronary heart disease.
        Am J Epidemiol. 1995; 142: 469-476
        • Siscovick D.S.
        • Raghunathan T.E.
        • King I.
        • Weinmann S.
        • Wicklund K.G.
        • Albright J.
        • Bovbjerg V.
        • Arbogast P.
        • Smith H.
        • Kushi L.H.
        • et al.
        Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
        JAMA. 1995; 274: 1363-1367
        • Wang L.
        • Folsom A.R.
        • Eckfeldt J.H.
        Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults.
        Nutr Metab Cardiovasc Dis. 2003; 13: 256-266
        • Wood D.A.
        • Riemersma R.A.
        • Butler S.
        • Thomson M.
        • Macintyre C.
        • Elton R.A.
        • Oliver M.F.
        Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease.
        Lancet. 1987; 1: 177-183
        • Leaf D.A.
        • Connor W.E.
        • Barstad L.
        • Sexton G.
        Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes.
        Am J Clin Nutr. 1995; 62: 68-73
        • Schwartz C.C.
        • VandenBroek J.M.
        • Cooper P.S.
        Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
        J Lipid Res. 2004; 45: 1594-1607
        • Harris W.S.
        • von Schacky C.
        The omega-3 index.
        Prev Med. 2004; 39: 212-220
        • Kark J.D.
        • Manor O.
        • Goldman S.
        • Berry E.M.
        Stability of red blood cell membrane fatty acid composition after acute myocardial infarction.
        J Clin Epidemiol. 1995; 48: 889-895
        • Sears B.
        The Omega Rx Zone. Regan Books, New York2003
        • Raatz S.K.
        • Bibus D.
        • Thomas W.
        • Kris-Etherton P.
        Total fat intake modifies plasma fatty acid composition in humans.
        J Nutr. 2001; 131: 231-234
        • Sarkkinen E.S.
        • Agren J.J.
        • Ahola I.
        • Ovaskainen M.L.
        • Uusitupa M.I.J.
        Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets.
        Am J Clin Nutr. 1994; 59: 364-370
        • Mohrhauer H.
        • Holman R.T.
        The effect of dose level of essential fatty acids upon fatty acid composition of rat liver.
        J Lipid Res. 1963; 58: 151-159
        • Mozaffarian D.
        • Ascherio A.
        • Hu F.B.
        • Stampfer M.J.
        • Willett W.C.
        • Siscovick D.S.
        • Rimm E.B.
        Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men.
        Circulation. 2005; 111: 166-173
        • Katan M.B.
        • Deslypere J.P.
        • van Birgelen A.P.
        • Penders M.
        • Zegwaard M.
        Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue.
        J Lipid Res. 1997; 38: 2012-2022
        • Kris-Etherton P.M.
        • Hecker K.D.
        • Binkoski A.E.
        Polyunsaturated fatty acids and cardiovascular health.
        Nutr Rev. 2004; 62: 414-426
        • Kris-Etherton P.M.
        • Harris W.S.
        • Appel L.J.
        Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
        Circulation. 2002; 106: 2747-2757
        • Krauss R.M.
        • Eckel R.H.
        • Howard B.
        • Appel L.J.
        • Daniels S.R.
        • Deckelbaum R.J.
        • Erdman Jr, J.W.
        • Kris-Etherton P.M.
        • Goldberg I.J.
        • Kotchen T.A.
        • et al.
        AHA dietary guidelines, revision 2000.
        Circulation. 2000; 102: 2284-2289
        • US Department of Health and Human Services
        Dietary Guidelines for Americans. 2005 (Available at: Accessed July 10, 2006.)